OBJECTIVE: To determine the prevalence of digenic mutations in patients with idiopathic hypogonadotropic hypogonadism (IHH) and Kallmann syndrome (KS). DESIGN: Molecular analysis of DNA in IHH/KS patients. SETTING: Academic medical center. PATIENT(S): Twenty-four IHH/KS patients with a known mutation (group 1) and 24 IHH/KS patients with no known mutation (group 2). INTERVENTION(S): DNA from IHH/KS patients was subjected to polymerase chain reaction-based DNA sequencing of the 13 most common genes (KAL1, GNRHR, FGFR1, KISS1R, TAC3, TACR3, FGF8, PROKR2, PROK2, CHD7, NELF, GNRH1, and WDR11). MAIN OUTCOME MEASURE(S): The identification of mutations absent in ≥188 ethnically matched controls. Both SIFT (sorting intolerant from tolerant) and conservation among orthologs provided supportive evidence for pathologic roles. RESULT(S): In group 1, 6 (25%) of 24 IHH/KS patients had a heterozygous mutation in a second gene, and in group 2, 13 (54.2%) of 24 had a mutation in at least one gene, but none had digenic mutations. In group 2, 7 (29.2%) of 24 had a mutation considered sufficient to cause the phenotype. CONCLUSION(S): When the 13 most common IHH/KS genes are studied, the overall prevalence of digenic gene mutations in IHH/KS was 12.5%. In addition, approximately 30% of patients without a known mutation had a mutation in a single gene. With the current state of knowledge, these findings suggest that most IHH/KS patients have a monogenic etiology.
OBJECTIVE: To determine the prevalence of digenic mutations in patients with idiopathic hypogonadotropic hypogonadism (IHH) and Kallmann syndrome (KS). DESIGN: Molecular analysis of DNA in IHH/KS patients. SETTING: Academic medical center. PATIENT(S): Twenty-four IHH/KS patients with a known mutation (group 1) and 24 IHH/KS patients with no known mutation (group 2). INTERVENTION(S): DNA from IHH/KS patients was subjected to polymerase chain reaction-based DNA sequencing of the 13 most common genes (KAL1, GNRHR, FGFR1, KISS1R, TAC3, TACR3, FGF8, PROKR2, PROK2, CHD7, NELF, GNRH1, and WDR11). MAIN OUTCOME MEASURE(S): The identification of mutations absent in ≥188 ethnically matched controls. Both SIFT (sorting intolerant from tolerant) and conservation among orthologs provided supportive evidence for pathologic roles. RESULT(S): In group 1, 6 (25%) of 24 IHH/KS patients had a heterozygous mutation in a second gene, and in group 2, 13 (54.2%) of 24 had a mutation in at least one gene, but none had digenic mutations. In group 2, 7 (29.2%) of 24 had a mutation considered sufficient to cause the phenotype. CONCLUSION(S): When the 13 most common IHH/KS genes are studied, the overall prevalence of digenic gene mutations in IHH/KS was 12.5%. In addition, approximately 30% of patients without a known mutation had a mutation in a single gene. With the current state of knowledge, these findings suggest that most IHH/KS patients have a monogenic etiology.
Authors: M Beranova; L M Oliveira; G Y Bédécarrats; E Schipani; M Vallejo; A C Ammini; J B Quintos; J E Hall; K A Martin; F J Hayes; N Pitteloud; U B Kaiser; W F Crowley; S B Seminara Journal: J Clin Endocrinol Metab Date: 2001-04 Impact factor: 5.958
Authors: Ning Xu; Hyung-Goo Kim; Balasubramanian Bhagavath; Sung-Gyu Cho; Jae Ho Lee; Kyungsoo Ha; Irene Meliciani; Wolfgang Wenzel; Robert H Podolsky; Lynn P Chorich; Kathryn A Stackhouse; Anna M H Grove; Lawrence N Odom; Metin Ozata; David P Bick; Richard J Sherins; Soo-Hyun Kim; Richard S Cameron; Lawrence C Layman Journal: Fertil Steril Date: 2011-02-15 Impact factor: 7.329
Authors: Grégoy Y Bédécarrats; Katja D Linher; Jo Ann Janovick; Milena Beranova; Faiza Kada; Stephanie B Seminara; P Michael Conn; Ursula B Kaiser Journal: Mol Cell Endocrinol Date: 2003-07-31 Impact factor: 4.102
Authors: Margaret E Wierman; John E Pawlowski; Melissa P Allen; Mei Xu; Daniel A Linseman; Sheila Nielsen-Preiss Journal: Trends Endocrinol Metab Date: 2004-04 Impact factor: 12.015
Authors: J P Hardelin; J Levilliers; S Blanchard; J C Carel; M Leutenegger; J P Pinard-Bertelletto; P Bouloux; C Petit Journal: Hum Mol Genet Date: 1993-04 Impact factor: 6.150
Authors: Philip L Beales; Jose L Badano; Alison J Ross; Stephen J Ansley; Bethan E Hoskins; Brigitta Kirsten; Charles A Mein; Philippe Froguel; Peter J Scambler; Richard Alan Lewis; James R Lupski; Nicholas Katsanis Journal: Am J Hum Genet Date: 2003-04-03 Impact factor: 11.025
Authors: Samuel D Quaynor; Lindsey Y Goldberg; Eun Kyung Ko; Robert K Stanley; Durkadin Demir; Hyung-Goo Kim; Lynn P Chorich; Richard S Cameron; Lawrence C Layman Journal: Mol Cell Endocrinol Date: 2013-12-04 Impact factor: 4.102
Authors: Qing Fang; Akima S George; Michelle L Brinkmeier; Amanda H Mortensen; Peter Gergics; Leonard Y M Cheung; Alexandre Z Daly; Adnan Ajmal; María Ines Pérez Millán; A Bilge Ozel; Jacob O Kitzman; Ryan E Mills; Jun Z Li; Sally A Camper Journal: Endocr Rev Date: 2016-11-09 Impact factor: 19.871